Form 4: Harvard Apparatus Regenerative Technology Director Chen Jing Acquires Stock Options

Sentiment:

SEC Form 4


Director Chen Jing receives stock options as part of annual equity grant and in lieu of cash compensation.

Summary

  • Director Chen Jing acquired stock options from Harvard Apparatus Regenerative Technology, Inc. on June 27, 2024.
  • The first stock option grant is for 10,204 shares at an exercise price of $2.92, vesting in four equal installments.
  • The vesting dates for the first grant are September 27, 2024, December 27, 2024, March 27, 2025, and June 27, 2025.
  • A second stock option grant is for 8,215 shares at an exercise price of $2.92, granted in lieu of cash compensation.
  • The vesting dates for the second grant are June 27, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
  • Both stock options expire on June 27, 2034.

Sentiment

Score: 6

Explanation: Routine director compensation; neither significantly positive nor negative.

Positives

  • The grants incentivize the director to contribute to the company's long-term success.

Industry Context

Stock option grants are a common form of compensation for directors, aligning their interests with those of shareholders.

Stakeholder Impact

  • The stock option grants align the director's interests with those of shareholders.

Key Dates

DateDescription
06/27/2024Date of stock option grants.
06/27/2024First vesting date for the second stock option grant.
06/30/2024Second vesting date for the second stock option grant.
09/27/2024First vesting date for the first stock option grant.
09/30/2024Third vesting date for the second stock option grant.
12/27/2024Second vesting date for the first stock option grant.
12/31/2024Fourth vesting date for the second stock option grant.
03/27/2025Third vesting date for the first stock option grant.
06/27/2025Fourth vesting date for the first stock option grant.
06/27/2034Expiration date for both stock options.
07/15/2024Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.